About Index Trending news
Analyze
Top 50 Pricing
Seattle Genetics

Seattle Genetics

Work at Seattle Genetics? Add yourself to this profile

Seattle Genetics

Biotechnology company focused on innovative monoclonal antibody-based therapies for the treatment of cancer. View our Twitter guidelines our site

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Post-IPO equity
$9,000,000
Employees

Unknown size

GeekWire

Seattle Genetics announces successful clinical trial of lymphoma treatment

The Motley Fool

Seattle Genetics Has Been Heating Up: Time to Buy?

The Motley Fool

Taking Inventory on Seattle Genetics, Inc. Earnings

Earnings Health Stock markets
The Motley Fool

Why Seattle Genetics, Inc. Stock Rose 10% in March

The Motley Fool

Seattle Genetics, Inc. Grows Sales, Waits for Data

Health Earnings
GeekWire

Despite record sales of cancer drug, Seattle Genetics shares fall 7 percent

Earnings Health